Anti-Cancer Light-Controllable Antibody-Peptide Conjugates

Project description

Selectively enhancing antibodies through light irradiation

Fields of science

• medical and health sciences › clinical medicine › cancer

Programme(s)

• H2020-EU.1.3.3. - Stimulating innovation by means of cross-fertilisation of knowledge

Topic(s)

• MSCA-RISE-2020 - Research and Innovation Staff Exchange

Call for proposal

H2020-MSCA-RISE-2020
See other projects for this call

Funding Scheme

MSCA-RISE - Marie Skłodowska-Curie Research and Innovation Staff Exchange (RISE)

Coordinator

ENAMINE LIMITED LIABILITY COMPANY,RESEARCH AND PRODUCTION ENTERPRISE

Address

78 Chervonotkatska Str.
02094 Kyiv
Ukraine

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EU contribution

€ 234 600

Participants (6)

KARLSRUHER INSTITUT FUER TECHNOLOGIE

Germany

EU contribution

€ 73 600

Address

Kaiserstrasse 12
76131 Karlsruhe

Activity type

Higher or Secondary Education Establishments

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE

United Kingdom

EU contribution

€ 78 200

Address

Trinity Lane The Old Schools
CB2 1TN Cambridge

Activity type

Higher or Secondary Education Establishments

LATVIJAS ORGANISKAS SINTEZES INSTITUTS

Latvia

EU contribution

€ 55 200

Address

Aizkraukles 21
1006 Riga

Activity type

Research Organisations

NATIONAL CANCER INSTITUTE

Ukraine

EU contribution

€ 73 600

Address

33/43 Lomonosova Street
03022 Kiyv

Activity type

Research Organisations

LUMOBIOTICS GmbH

Germany

EU contribution

€ 165 600

Address

Auerstrasse 2
76227 Karlsruhe

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

STICHTING VUMC

Netherlands

EU contribution

€ 64 400

Address

De Boelelaan 1117
1081 HV Amsterdam

Activity type

Research Organisations